Screening using BNP may prevent heart failure, study says

03/13/2013 | MedPage Today (free registration)

Screening patients at risk for heart failure but without symptoms, and then beginning treatment based on B-type natriuretic peptide levels, reduced the risk of hospitalization for heart failure and left ventricular dysfunction, according to a study from University Hospital in Dublin presented at the American College of Cardiology meeting. Researcher Dr. Kenneth McDonald said the study shows that BNP screening could have "a significant impact on the development of new-onset heart failure."

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC